Pfizer's most recent trend suggests a bullish bias. One trading opportunity on Pfizer is a Bull Put Spread using a strike $41.00 short put and a strike $36.00 long put offers a potential 9.17% return on risk over the next 20 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $41.00 by expiration. The full premium credit of $0.42 would be kept by the premium seller. The risk of $4.58 would be incurred if the stock dropped below the $36.00 long put strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Pfizer is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Pfizer is bullish.
The RSI indicator is at 75.2 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Pfizer
Pfizer opens $236M facility as region makes gains in biotech industry
Thu, 30 May 2019 19:26:23 +0000
Pfizer's new facility comes online as St. Louis' recognition as a national hub for life sciences continues to grow.
Should We Worry About Pfizer Inc.'s (NYSE:PFE) P/E Ratio?
Thu, 30 May 2019 17:30:20 +0000
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios…
Only five Dow stocks have gained in May as trade war drags on
Thu, 30 May 2019 16:59:37 +0000
UnitedHealth, Pfizer, Travelers Companies, Merck and McDonald's were the only stocks of the Dow 30 in positive territory for the month in intraday trading Thursday. Dow, 3M, Intel, Caterpillar and Apple, the worst performers in May, were each down at least 11% for the month. The blue-chip Dow has shed more than 1,400 points (5.5%) in May as a breakdown in trade relations triggered a new tariff wave between the U.S. and China.
Pfizer (PFE) Up 2.3% Since Last Earnings Report: Can It Continue?
Thu, 30 May 2019 13:31:01 +0000
Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Pfizer focuses on regional China after price cuts hit sales
Thu, 30 May 2019 01:03:10 +0000
US drugmaker Pfizer is turning its attention to remoter regions of China in an effort to offset the impact of government policies on sales of its bestselling drug Lipitor in large cities. , but last year it lost a tender to sell anti-cholesterol drug Lipitor to state-run hospitals in 11 of China’s largest cities to local generic rivals, which undercut it on price.
Also on Market Tamer…
Follow Us on Facebook